FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(079937015)" | Midazolam Hydrochloride | 3000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | Morphine Sulfate | 1500 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-517 | 70092-517-43 | Morphine Sulfate | 1 mg/1 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-521 | 70092-521-74 | Morphine Sulfate | 50 mg/50 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Morphine Sulfate | 1500 mg/1500 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-520 | 70092-520-49 | Morphine Sulfate | 30 mg/30 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-523 | 70092-523-50 | Morphine Sulfate | 50 mg/50 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-519 | 70092-519-48 | Morphine Sulfate | 30 mg/30 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-522 | 70092-522-35 | Morphine Sulfate | 50 mg/50 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-380 | 70092-380-36 | Morphine Sulfate | 100 mg/100 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-518 | 70092-518-75 | Morphine Sulfate | 100 mg/100 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-133 | 70092-133-43 | Morphine Sulfate | 2 mg/2 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Morphine Sulfate | 3000 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | Morphine Sulfate | 250 mg/500 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-132 | 70092-132-43 | Morphine Sulfate | 1 mg/2 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-229 | 70092-229-43 | Atropine Sulfate | 1 mg/2.5 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 1000 ug/10 mL | 2026-1 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Phenylephrine Hydrochloride | 120 mg/3000 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "RC Outsourcing, LLC(079935629)" | Bevacizumab | 25 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine; Benzocaine; Tetracaine | 60 mg/1 g; 200 mg/1 g; 40 mg/1 g | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine; Tetracaine | 230 mg/1 g; 70 mg/1 g | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "RC Outsourcing, LLC(079935629)" | Lidocaine; Tetracaine; Phenylephrine Hydrochloride | 200 mg/1 g; 60 mg/1 g; 20 mg/1 g | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .16 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .04 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Rocuronium Bromide | 10 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .032 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .02 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Epinephrine | .016 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2026-1 | source_no_ndc | 2026-10-06 |